Far Infrared Treatment for Alzheimer's Disease

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00599469

Enrollment

Registered

2008-01-23

Start date

2008-02-29

Completion date

2009-04-30

Last updated

2009-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Acute Confusional Senile Dementia, Alzheimer Type Senile Dementia, SENILE PLAQUES, NEUROFIBRILLARY TANGLES, NEUROPIL THREADS

Brief summary

Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.

Detailed description

Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal. Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.

Interventions

RADIATIONFar Infrared Radiation (5μm to 20μm wavelength)

Far Infrared radiation for 30 to 40 minutes per treatment session.

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* People with Alzheimer's disease

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Management and Cure of Alzheimer's Disease	1 year

Secondary

Measure	Time frame
Management and Cure of Dementia	1 year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026